GrantComerMD

Ophthalmology • Ann Arbor, MI

Retinal Disease

Associate Professor, University of Michigan Kellogg Eye Center

Join to view full profile

Dr. Comer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Comer's full profile

Already have an account?

Office
1000 Wall Street
Ann Arbor, MI 48105
Phone+1 734-763-5874

Fax+1 734-232-0865

Summary

Dr. Grant Comer is a retina specialist who sees patients at the University of Michigan Kellogg Eye Center’s offices in Ann Arbor and Brighton. His clinical practice focuses on the medical and surgical management of the retina and vitreous, including diagnosis and treatment of ocular melanoma, retinal detachments, diabetic retinopathy, age-related macular degeneration, retinal vascular disease, ocular trauma, and infectious chorioretinitis.

Dr. Comer’s research interests include the diagnosis and management of infectious chorioretinitis with particular focus on drug-resistant organisms and how they relate to ocular disease. To make an appointment, please call Kellogg’s Retina and Uveitis Clinic at 734-763-5874 or Kellogg’s Brighton office at 810-227-2357. To refer a patient, please visit www.kellogg.umich.edu/refer.

Education & Training

University of Michigan, Rackham Graduate SchoolM.Sc., Clinical Research Design and Statistical Analysis, 2007 - 2009
Indiana University School of MedicineResidency, Ophthalmology, 2002 - 2005
Indiana University School of Medicine/Methodist HospitalInternship, Transitional Year, 2001 - 2002
Indiana University School of MedicineClass of 2001
Wabash CollegeA.B., Biology, Magna Cum Laude, 1993 - 1997

Certifications & Licensure

MI State Medical License 2005 - 2027
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
April Employee of the Month W.K. Kellogg Eye Center, 2011
Achievement Ribbon University of Michigan Annual Clinical Research Training Symposium, 2008
Resident Teaching Award University of Michigan Kellogg Eye Center, 2007
Resident’s Day Award Indiana University Department of Ophthalmology, 2004
Ophthalmology Academic Chief Resident Indiana University Department of Ophthalmology, Elected by peers, approved by faculty, 2004
NCAA Postgraduate Scholarship 1997
Phi Beta Kappa 1997
Varsity Swimming Team Captain Wabash College, 1995
Wherrett Memorial Scholarship 1993
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

Clinical Trials

Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration Start of enrollment: 2012 Oct 01
Terminated
Phase 2, Phase 3
Treatment for CI-DME in Eyes With Very Good VA Study Start of enrollment: 2013 Oct 01
Completed
Phase 3
A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel Start of enrollment: 2014 Apr 01
Completed
Phase 2
Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema Start of enrollment: 2012 Sep 01
Completed
Join now to see all

Publications & Presentations

PubMed

1 citations
Severe Spontaneous Tilt of Scleral-Fixated Intraocular Lenses.
Jennifer M Enright, Boonkit Purt, Brent Bruck, Parth Shah, Emily Eton
American Journal of Ophthalmology. 2024-06-01
7 citations
Intraretinal pigmented cells in retinal degenerative disease.
Marina Yasvoina, Qian Yang, Sasha M Woods, Tjebo Heeren, Grant M Comer
The British Journal of Ophthalmology. 2023-11-01
20 citations
Novel TMEM98, MFRP, PRSS56 variants in a large United States high hyperopia and nanophthalmos cohort.
Lev Prasov, Bin Guan, Ehsan Ullah, Steven M. Archer, Bernadete Ayres
Scientific Reports. 2020-11-17

Journal Articles

Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No 3
Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Wang JJ, Mitchell P, Ramdas WD, Vingerling JR, Macular Telangiectasia Project Research Group, Ophthalmic Epidemiology, 1/1/2013
En face OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia
Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UEK, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC, MacTel Study Group, Investigative Ophthalmology and Visual Science, 1/1/2012
Identifiction of a Potential Susceptibility Locus for Macular Telangiectasia Type 2
Parmalee NL, Schubert C, Figueroa M, Bird AC, Peto T, Gillies MC, Bernstein PS, Kiryluk K, Terwilliger JD, Allikmets R, MacTel Study Group, PLoS ONE, 1/1/2012
The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia
Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UEK, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC, MacTel Study Group, Investigative Ophthalmology & Visual Science, 1/1/2012
Retinoblastoma in a 48-year-old woman
Wells JR, Aaberg TM, Jr., Shields CL, Comer GM, Grossniklaus HE, Retinal Cases and Brief Reports, 1/1/2011
Intravitreal daptomycin: A safety and efficacy study
Comer GM, Miller JB, Schneider EW, Khan NW, Reed DM, Elner VM, Zacks DV, Retina, 1/1/2011
Retinal Crystals in Type 2 Idiopathic Macular Telangiectasia
Sallo FB, Leung I, Chung M, Wolf-Schnurrbusch UEK, Dubra A, Williams DR, Clemons T, Pauleikhoff D, Bird AC, Peto T, MacTel Study Group, Ophthalmology, 1/1/2011
Baseline Characteristics of Participants in the Natural History Study of Macular Telangiectasia (MacTel) MacTel Project Report No 2
Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Figueroa MJ, Harrington MW, MacTel Research Group, Ophthalmic Epidemiology, 1/1/2010
Corticosteroids for Diabetic Macular Edema
Comer GM, Ciulla TA, Review of Ophthalmology, 2/1/2009
Vitreous penetration of orally administered famciclovir
Chong DY, Johnson MW, Huynh, TH, Hall, EF, Comer GM, Fish DN, American Journal of Ophthalmology, 1/1/2009
Vitreous penetration of orally administered valacyclovir
Huynh TH, Johnson MW, Comer GM, Fish D, American Journal of Ophthalmology, 1/1/2008
Optical coherence tomographic identification of retinal fold resolution in chronic hypotonus maculopathy after internal limiting membrane removal
Comer GM, Danis RP, Annals of Ophthalmology, 1/1/2005
MV-6401, a potent photosensitizer: a review of the current state of photosensitizing agents for the treatment of exudative age-related macular degeneration
Ciulla TA, Oliver A, Comer GM, Drugs of the Future, 1/1/2005
Pharmacotherapy for diabetic retinopathy
Comer GM, Ciulla TA, Review of Ophthalmology, 9/1/2004
Is there a connection between LASIK and RRD? The literature highlights the continuing controversy
Comer G, Ciulla TA, Cataract & Refractive Surgery Today, 10/1/2003
Join now to see all

Lectures

The Pass Machine Geriatric Medicine Maintenance of Certification Exam Prep Course
American Physician Institute for Advanced Professional Studies, Santa Monica, California - 9/12/2012